Who is affected by this change?

This affects Independence Blue Cross Psychiatry, Neurology providers on Medicare Advantage plans.

When does this change take effect?

This change is effective Dec 29, 2025.

Back to dashboard

Medicare AdvantageAdministrativeLow impact

MA07.035f, Therapeutic Transcranial Magnetic Stimulation (TMS)

Independence Blue Cross·Psychiatry, Neurology·Medical Policy

Effective date

Dec 29, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

Medicare Advantage policy MA07.035f for Therapeutic Transcranial Magnetic Stimulation (TMS) has been updated with general description, guidelines, or informational changes. This appears to be a routine policy refresh rather than a major coverage or billing change.

Action Required

Action needed

By December 29, 2025: Billing team should review the updated MA07.035f TMS policy at the source URL to understand any changes to coverage guidelines or documentation requirements for TMS procedures. Verify current billing practices align with updated policy language.

Related policy hubs

Independence Blue Cross policies Psychiatry Neurology